Literature DB >> 24777307

Suppressive action of acetate on interleukin-8 production via tubulin-α acetylation.

Kazuhiro Ishiguro1, Takafumi Ando1, Osamu Maeda1, Osamu Watanabe1, Hidemi Goto1.   

Abstract

Acetate is the major short-chain fatty acid produced by commensal bacteria in the gut and is known as a nutrient source for epithelial cells of the mucosa. Acetate also suppresses interleukin (IL)-2 production in T cells by inhibiting nuclear factor of activated T cells (NFAT) nuclear translocation via tubulin-α acetylation. Using acetylation of tubulin-α as a biomarker, we have examined the influence of acetate in the large intestine. Because of high concentrations of acetate in fecal material, tubulin-α acetylation is dominant in the proximal large intestine relative to other sections of the large intestine and is induced in epithelial cells of the colonic mucosa. Flagellin stimulation induces IL-8 production in epithelial cells and acetate suppresses this IL-8 production via tubulin-α acetylation. Flagellin stimulation activates nuclear factor-κB, CREB and AP-1, but not NFAT. Of these transcription factors, acetate specifically inhibits AP-1 activation. Acetate impairs flagellin-induced activation of the Rap1-MEK-ERK-Elk-1 pathway with acetylation of tubulin-α that is bound to Rap1, resulting in reduced expression of c-Fos, a subunit of AP-1. These findings reveal a novel action of acetate via tubulin-α acetylation in epithelial cells of the colonic mucosa.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24777307     DOI: 10.1038/icb.2014.31

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  6 in total

1.  Comparative Effect of the I3.1 Probiotic Formula in Two Animal Models of Colitis.

Authors:  Violeta Lorén; Josep Manyé; Mari C Fuentes; Eduard Cabré; Isabel Ojanguren; Jordi Espadaler
Journal:  Probiotics Antimicrob Proteins       Date:  2017-03       Impact factor: 4.609

Review 2.  Tubulin acetylation: responsible enzymes, biological functions and human diseases.

Authors:  Lin Li; Xiang-Jiao Yang
Journal:  Cell Mol Life Sci       Date:  2015-07-31       Impact factor: 9.261

3.  Probiotic Bifidobacterium longum alters gut luminal metabolism through modification of the gut microbial community.

Authors:  Hirosuke Sugahara; Toshitaka Odamaki; Shinji Fukuda; Tamotsu Kato; Jin-zhong Xiao; Fumiaki Abe; Jun Kikuchi; Hiroshi Ohno
Journal:  Sci Rep       Date:  2015-08-28       Impact factor: 4.379

4.  Physiological Concentration of Exogenous Lactate Reduces Antimycin A Triggered Oxidative Stress in Intestinal Epithelial Cell Line IPEC-1 and IPEC-J2 In Vitro.

Authors:  Stefan Kahlert; Sami Junnikkala; Lydia Renner; Ulla Hynönen; Roland Hartig; Constanze Nossol; Anikó Barta-Böszörményi; Sven Dänicke; Wolfgang-Bernhard Souffrant; Airi Palva; Hermann-Josef Rothkötter; Jeannette Kluess
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

5.  The Immune-Modulator Pidotimod Affects the Metabolic Profile of Exhaled Breath Condensate in Bronchiectatic Patients: A Metabolomics Pilot Study.

Authors:  Maria D'Amato; Debora Paris; Antonio Molino; Paola Cuomo; Andrea Fulgione; Nunzia Sorrentino; Letizia Palomba; Mauro Maniscalco; Andrea Motta
Journal:  Front Pharmacol       Date:  2019-10-03       Impact factor: 5.810

Review 6.  Immunomodulation by the Commensal Microbiome During Immune-Targeted Interventions: Focus on Cancer Immune Checkpoint Inhibitor Therapy and Vaccination.

Authors:  Abigail L Reens; Damien J Cabral; Xue Liang; James E Norton; Alex G Therien; Daria J Hazuda; Gokul Swaminathan
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.